Accessibility Screen-Reader Guide, Feedback, and Issue Reporting | New window
Clear
Log in to access Online Inquiry
Back to the Top
To create a seamless experience and for website quality and improvement purposes, we use cookie technologies for verification and quality purposes, to personalize the content presented, and to provide advertising that may be of specific interest to you. Learn our Privacy Policy here.
Accept All
Reject All
Headlines
Earnings Call Summary | Cellebrite(CLBT.US) Q1 2026 Earnings Conference
Earnings Call Summary | Cellebrite(CLBT.US) Q1 2026 Earnings Conference
moomoo AI · May 14 16:52
CLBT +8.43%
The following is a summary of the Cellebrite DI Ltd. (CLBT) Q1 2026 Earnings Call Transcript:
Financial Performance:
Cellebrite reported a 21% year-over-year growth in ARR, reaching $493 million.
Adjusted EBITDA rose 29% year-over-year to $30.6 million.
Free cash flow margin for the trailing twelve months was 32%.
Company holds $535 million in cash and equivalents, maintaining a solid liquidity position.
Business Progress:
Successfully launched Genesis, an advanced AI solution, seeing significant early adoption with over 500 registered users from various agencies across 15 countries.
Achieved FedRAMP high authorization, enabling expanded service offerings to U.S. federal agencies.
Notable advancements in device unlocking capabilities and strategic acquisitions such as Corellium and SCG have strengthened their technological edge.
Financial Guidance:
Expecting Q2 ARR to be in the range of $510 million to $513 million.
Q2 revenue projected to be between $130 million and $133 million, signaling a 15% to 17% increase.
Anticipate adjusted EBITDA for Q2 to be between $29 million and $31 million.
The guidance accounts for FX headwinds and expanded investment in user conferences.
Opportunities:
Broadening TAM via AI advancements in digital evidence analytics, which could potentially double the company's business.
The FedRAMP authorization opens substantial opportunities in government cloud offerings.
Emerging market needs in cybersecurity, propelled by global geopolitical instabilities, align with Cellebrite's expanded capabilities and services.
Risks:
No explicit risks detected.
More details: Cellebrite IR
Tips: This article is generated by AI. The accuracy of the content can not be fully guaranteed. For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Like
Views 394
Recommended
TakadaKiko Steel Constr FY Parent Loss Y535.00M Vs Net Y343.00M
Dow Jones · 5m
Singapore Exchange Target Price Raised to S$20.90 From S$20.30 by RHB Research >S68.SG
Dow Jones · 1m
Plaid 1H Net Y310.00M Vs Net Y641.00M
Dow Jones · 4m
TOW Co Ltd 9-Mos Net Y910.00M Vs Net Y916.00M
Dow Jones · 4m
SBS Holdings Inc Sees 1H Net Y9.50B
Dow Jones · 4m
Write a comment
No comments yet. Write one.